230 related articles for article (PubMed ID: 29197387)
1. Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease.
Liu Y; Jiang X; Chen X
Lipids Health Dis; 2017 Dec; 16(1):227. PubMed ID: 29197387
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
Anholm C; Kumarathurai P; Pedersen LR; Samkani A; Walzem RL; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Atherosclerosis; 2019 Sep; 288():60-66. PubMed ID: 31326727
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus.
Keskin L; Yaprak B
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6813-6820. PubMed ID: 36196729
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Wang L; Xin Q; Wang Y; Chen Z; Yuan R; Miao Y; Zhang G; Cong W
Pharmacol Res; 2021 Sep; 171():105765. PubMed ID: 34252552
[TBL] [Abstract][Full Text] [Related]
5. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
[TBL] [Abstract][Full Text] [Related]
6. Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 Analogues and Metformin in the Treatment of Obese Patients with Poorly Regulated Postprandial Glycemia.
Buturovic BA; Ristic LB; Narancic AM
Med Arch; 2014 Oct; 68(5):313-6. PubMed ID: 25568561
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV; Barrientos-Pérez M; Fainberg U; Frimer-Larsen H; Hafez M; Hale PM; Jalaludin MY; Kovarenko M; Libman I; Lynch JL; Rao P; Shehadeh N; Turan S; Weghuber D; Barrett T;
N Engl J Med; 2019 Aug; 381(7):637-646. PubMed ID: 31034184
[TBL] [Abstract][Full Text] [Related]
8. Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
Anholm C; Kumarathurai P; Klit MS; Kristiansen OP; Nielsen OW; Ladelund S; Madsbad S; Sajadieh A; Haugaard SB;
BMJ Open; 2014 Jul; 4(7):e005942. PubMed ID: 25031198
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of therapeutic effect of metformin hydrochloride/vildagliptin and liraglutide on type 2 diabetes mellitus in obese patients].
Zhou B; Li J; Fang C; Huang Y; Sang G; Tao S; He C
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):436-442. PubMed ID: 37087589
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
Anholm C; Kumarathurai P; Pedersen LR; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Diabetes Obes Metab; 2017 Jun; 19(6):850-857. PubMed ID: 28124822
[TBL] [Abstract][Full Text] [Related]
11. Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study.
Kumarathurai P; Sajadieh A; Anholm C; Kristiansen OP; Haugaard SB; Nielsen OW
Cardiovasc Diabetol; 2021 Jan; 20(1):12. PubMed ID: 33413428
[TBL] [Abstract][Full Text] [Related]
12. Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial.
Tanaka K; Saisho Y; Manesso E; Tanaka M; Meguro S; Irie J; Sugiura H; Kawai T; Jinzaki M; Cobelli C; Itoh H;
Clin Drug Investig; 2015 Oct; 35(10):675-84. PubMed ID: 26369653
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
Tian F; Zheng Z; Zhang D; He S; Shen J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M; Rizvi AA; Patti AM; Nikolic D; Giglio RV; Castellino G; Li Volti G; Caprio M; Montalto G; Provenzano V; Genovese S; Ceriello A
Cardiovasc Diabetol; 2016 Dec; 15(1):162. PubMed ID: 27912784
[TBL] [Abstract][Full Text] [Related]
15. Effect of liraglutide vs. NPH in combination with metformin on blood glucose fluctuations assessed using continuous glucose monitoring in patients with newly diagnosed type 2 diabetes.
Ma Z; Chen R; Liu Y; Yu P; Chen L
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):933-9. PubMed ID: 26365337
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F
Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456
[TBL] [Abstract][Full Text] [Related]
17. Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial.
Feng WH; Bi Y; Li P; Yin TT; Gao CX; Shen SM; Gao LJ; Yang DH; Zhu DL
J Diabetes Investig; 2019 Mar; 10(2):399-407. PubMed ID: 29957886
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial.
Kajiwara M; Tanaka A; Kawasaki T; Nakao K; Sakamoto T; Toyoda S; Inoue T; Koga N; Node K
J Cardiol; 2017 Mar; 69(3):511-517. PubMed ID: 27894787
[TBL] [Abstract][Full Text] [Related]
19. Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
Anholm C; Kumarathurai P; Samkani A; Pedersen LR; Boston RC; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Diabetes Obes Metab; 2019 Aug; 21(8):2012-2016. PubMed ID: 31050161
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease.
Feng W; Gao C; Bi Y; Wu M; Li P; Shen S; Chen W; Yin T; Zhu D
J Diabetes; 2017 Aug; 9(8):800-809. PubMed ID: 28332301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
